All lobbying filings

CHECKMATE GOVERNMENT RELATIONS

CHECKMATE GOVERNMENT RELATIONS filed a Q3 report for REPLIMUNE, INC. on October 18, 2026, reporting $120,000 in lobbying income.

Lobbying for REPLIMUNE, INC. · Biotech company focused on resolution of cancer treatment

All filings by CHECKMATE GOVERNMENT RELATIONS · Everything REPLIMUNE, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 18, 2026

Income

$120,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to FDA approval processes and procedures.

Medical/Disease Research/Clinical Labs

Issues related to FDA approval processes and procedures.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.